2015
DOI: 10.3389/fimmu.2015.00265
|View full text |Cite
|
Sign up to set email alerts
|

Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
28
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 25 publications
(28 citation statements)
references
References 55 publications
0
28
0
Order By: Relevance
“…Given that cumulative signals are important determinants of ADCC susceptibility, future research should assess if target cells infected with viruses coding for wild-type Nef become susceptible to ADCC after blockade of inhibitory NK cell receptors. Such studies could generate potential therapeutic avenues for eliminating HIV-1-infected cells important for curative efforts to eliminate reactivated HIV-1 (39). Finally, whether ligands for other activating or coactivating receptors expressed on HIV-1-infected cells also participate in this cumulative activating signal and modulate ADCC susceptibility remain to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Given that cumulative signals are important determinants of ADCC susceptibility, future research should assess if target cells infected with viruses coding for wild-type Nef become susceptible to ADCC after blockade of inhibitory NK cell receptors. Such studies could generate potential therapeutic avenues for eliminating HIV-1-infected cells important for curative efforts to eliminate reactivated HIV-1 (39). Finally, whether ligands for other activating or coactivating receptors expressed on HIV-1-infected cells also participate in this cumulative activating signal and modulate ADCC susceptibility remain to be determined.…”
Section: Discussionmentioning
confidence: 99%
“…Non-NAbs capable of mediating ADCC by recruiting Fcγ receptor (FcγR) IIIa–bearing cells such as, NK cells, are of interest as immune therapies to reduce the size of the latent reservoir because these antibodies can target Env on the surface of primary virus–infected cells [44]. The use of mAb-based molecules that can recognize and promote infected cell killing combined with cART is a promising new strategy for treating HIV-1 infection [45–47].…”
Section: Hurdles In Eliminating the Latent Reservoirmentioning
confidence: 99%
“…Cytolysis of reactivated cells harboring HIV-1 provirus could theoretically be achieved via antibody-dependent cellular cytotoxicity (ADCC) (10). Anti-HIV-1 antibodies trigger ADCC upon binding cell surface viral proteins and the IgG constant region receptor, Fc␥RIIIa or CD16, of effector cells such as natural killer (NK) cells and monocytes (11)(12)(13).…”
mentioning
confidence: 99%